Merck ′s new biotech development center will be set up in Switzerland and is expected to bridge the gap between research and manufacturing. With this facility, the company aims to make new medicines quickly available to patients.Corsier-sur-Vevey/Switzerland - Merck has recently announced an investment of 275 million dollars in a new facility in Corsier-sur-Vevey, Switzerland - the Merck Biotech Development Center - dedicated to biotech development and manufacturing for clinical studies. Driven by the growth of the Healthcare business sector R&D pipeline, this investment will help to sustainably secure capacity and high agility to deliver clinical trial material in ...